期刊文献+

经尿道前列腺汽化电切术治疗前列腺增生症 被引量:15

Transurethral vaporized resection of the prostate for benign prostatic hyperplasia(215 cases report)
原文传递
导出
摘要 目的探讨经尿道前列腺汽化电切术治疗良性前列腺增生(BPH)的疗效。方法采用经尿道前列腺汽化切割并电切术(TUVP)治疗前列腺增生患者215例,年龄58~93岁,平均69-4岁,病程1个月~8年,术前IPSS评分平均为30.2分。结果所有手术均取得成功,无一例转为开放手术,平均手术时间50min,术中无输血,未出现严重的并发症。术后随访1年以上67例,其中短暂尿失禁8例,经保守治疗后均于1个月内恢复。术后IPSS评分平均8.6分;平均最大尿流率(Qmax)18.8mVs,与术前比较差异均有统计学意义。结论将电切与汽化切割相结合行经尿道前列腺切除是一种微创、安全性高且疗效确切的BPH治疗方法。 Objective To explore the clinical efficacy of transurethral vaporized resection of the prostate (TUVP) for benign prostatic hyperplasia (BPH). Methods 215 cases with BPH underwent TUVP whose ages ranged from 58 to 93 years (mean 69.4). Duration of BPH was 1 month to 8 years. The mean IPSS before operation was 30.2. Results All the operations were achieved success without severe compli- cations and blood transfusion. No one was transferred to open surgery. With over 1-year follow-up in 67 cases, 8 patients were incontinent transiently and were continent after expectant treatment. The mean IPSS after the operations was 8.6, Qmax was 18.8 ml/s. There was significatit different from preoperation. Conelusions Transurethral vaporized resection of the prostate(TUVP) for benign prostatic hyperplasia(BPH) was minimal invasive, safe and effective.
出处 《中华腔镜泌尿外科杂志(电子版)》 2009年第4期23-25,共3页 Chinese Journal of Endourology(Electronic Edition)
  • 相关文献

参考文献3

二级参考文献15

  • 1[1]Holtgrewe HL.Tramurethral prostatectomy.Urol Clin North Am,1995,12(2):357-363.
  • 2[2]Puchner PJ.Miller MI.The effect of finasterid on hematuria associ ated with benign prostatic hyperplasia:a preliminary report.J Urol,1995.154:1779-1782.
  • 3[3]Shih SJ,Dall-Era MA,Westphal JR,et al.Elements regularing angiogenesis and correlative mierovessel density in benign hyper plastic and malignat prostate tissue.Prostate Cancer Prostatic Dis,2003.6:131-137.
  • 4[4]Baileyo DM,Foley SJ.Microvascular anatomy in patients with re current haematuria related to prostatic hypertrophy.J Urol,1999,161:865.
  • 5[5]Mc Connell JD,Bruskewitz R,Walsh PC,et al.The effect of finesteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia:fi nasteride long tertn efficacy and safety study group.N Engl J Med,1998,338(4):557-563.
  • 6[6]Foley SJ,Soloman Lz,Wedderbum AW,et al.A prospective atudy of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of fimteride.J Urol,2000,163(2):496-498.
  • 7[7]Haggstrom S,Toning N,Moller K,et al.Effects of finasteride on vascular endothelial growth factor.ScandJ Urol Nephrol,2002,36(3):182-187.
  • 8Narayan P, Tewari A, Garzotto M, et al. Transurethral vaportrode electrovaporization of the prostates physical principles, technique, and results [J]. Urology, 1996, 47(4):505-511.
  • 9Desautel MG, Burney TL, Diaz DA, et al. Outcome of vaportrode transurethral vaporization of the prostate using pressure-flow urodynamic criteria [J]. Urology, 1998, 51(6):1013-1021.
  • 10Hammadeh MY, Madan S, Hines J, et al. 52 year outcome of a prospective randomized trial to compare transurethral electrovaporization of the prostate and standard transurethral resection [J]. Urology, 2003, 61(6):1166-1174.

共引文献9

同被引文献64

引证文献15

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部